Lysozyme nephropathy in chronic myelomonocytic leukemia.
hematology
nephrology
oncology
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
17
01
2019
revised:
09
04
2019
accepted:
16
04
2019
entrez:
12
6
2019
pubmed:
12
6
2019
medline:
12
6
2019
Statut:
epublish
Résumé
Lysozyme nephropathy is a frequently unrecognized cause of renal disease in chronic myelomonocytic leukemia and may serve as a novel indication for treatment in this patient population. We demonstrate that in newly diagnosed CMML patients, plasma lysozyme levels are positively correlated with both absolute monocyte count and serum creatinine.
Identifiants
pubmed: 31183108
doi: 10.1002/ccr3.2188
pii: CCR32188
pmc: PMC6553339
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1263-1264Déclaration de conflit d'intérêts
None declared.
Références
Clin Case Rep. 2019 May 10;7(6):1263-1264
pubmed: 31183108
N Engl J Med. 1968 Sep 5;279(10):506-12
pubmed: 5671455
Lab Invest. 1982 Feb;46(2):149-57
pubmed: 7062720